Super happy, it is both a privilege and a great responsability, but oh boy! the satisfaction, the excitment is beyond words. Check out, my group is finally here. #newPI https://t.co/q9O6O1Hkrh
“French physicist and media star loses doctorate after plagiarism investigation” found “copy-pasted material” in two-thirds of his thesis.
https://t.co/BnN5UPfrMl
https://t.co/VFDMohWzUc
What an amazing event. Thank you @chadtough for such an incredible experience and for funding our work @KidsCancerInst. Together in the fight against DIPG.
1/ Delighted to share the published version of this work from brilliant #CancerNeuroscience post-doc @TaraBarronPhD detailing GABAergic neuron-to-glioma synapses in #DIPG/#DMG. 🧵
Open access link:
https://t.co/n6kvjrVrjb
The CBDD lab at #CCIResSymp@KidsCancerInst. And no, we didn't coordinate the dress code🤣🤣. Congrats to Josh on his oustanding talk on how we are using unnorthodox methods to target DMGs
Today we welcome @DonaAnnJOHNS1 who joins my lab at @KidsCancerInst as our new Research Officer. Dona expertise in paediatric oncology and epigenetics is timely in our efforts to develop a targeted therapy for DIPG.
We’re thrilled to celebrate the appointment of four of our incredible researchers to Associate Professor.
Join us in congratulating these extraordinary researchers: @charles_debock@EmmyFleuren@FaValdesMora & Michelle Henderson
Looking for a medicinal chemist and a research assistant to join my lab at @KidsCancerInst. Please DM me if you are interested in cancer drug discovery and paediatric CNS tumours.
Já pensou poder tratar um câncer sem ter que lidar com os efeitos colaterias dos tratamentos atuais?
Austrália tem o único grupo de pesquisa para medicamento que poderá ser alternativa à quimioterapia.
https://t.co/HG7ZURzm8z
A bold research project at @KidsCancerInst that could lead to the first-ever effective drug to treat deadly brain cancer, #DIPG, received a major boost this month, with a $US400,000 grant awarded to @Jean_Bertoldo by the US-based charity, @ChadTough. https://t.co/dWDZ5tcdPO
We are recruiting! A Research Officer position to work on our recently funded @chadtough grant @KidsCancerInst. Interested in cancer drug discovery and paediatric brain cancer? Please follow the links. https://t.co/wjuUfT6yB1
Research Officer (https://t.co/AqLqlql7Qx)
Super happy and grateful to @chadtough for funding our work on developing H3K27M-targeting chemical probes. Attacking the Achilles' heel of DIPG might be the crucial step toward eradicating this incurable cancer. @KidsCancerInst#NewInvestigatorGrant
Chromatin-targeted drug discovery at “a very special moment” https://t.co/PTtXHQsXnx
Cigall Kadoch, a researcher at Dana-Farber Cancer Institute & co-founder of Foghorn Therapeutics, discusses the case for a new wave of epigenetic drugs targeting chromatin remodelling complexes